Logo image of IDL.CA

IMAGING DYNAMICS CO LTD (IDL.CA) Stock Fundamental Analysis

Canada - TSX-V:IDL - CA4519205088 - Common Stock

0.03 CAD
0 (0%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

1

Overall IDL gets a fundamental rating of 1 out of 10. We evaluated IDL against 16 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of IDL have multiple concerns. IDL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IDL had negative earnings in the past year.
IDL had a negative operating cash flow in the past year.
In the past 5 years IDL always reported negative net income.
IDL had a negative operating cash flow in each of the past 5 years.
IDL.CA Yearly Net Income VS EBIT VS OCF VS FCFIDL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of IDL (-704.59%) is worse than 82.35% of its industry peers.
Industry RankSector Rank
ROA -704.59%
ROE N/A
ROIC N/A
ROA(3y)-343.3%
ROA(5y)-260.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IDL.CA Yearly ROA, ROE, ROICIDL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400

1.3 Margins

With an excellent Gross Margin value of 67.79%, IDL belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
In the last couple of years the Gross Margin of IDL has declined.
The Profit Margin and Operating Margin are not available for IDL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.86%
GM growth 5Y-2.44%
IDL.CA Yearly Profit, Operating, Gross MarginsIDL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

1

2. Health

2.1 Basic Checks

IDL does not have a ROIC to compare to the WACC, probably because it is not profitable.
IDL has about the same amout of shares outstanding than it did 1 year ago.
IDL has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IDL has a worse debt to assets ratio.
IDL.CA Yearly Shares OutstandingIDL.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IDL.CA Yearly Total Debt VS Total AssetsIDL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

IDL has an Altman-Z score of -838.82. This is a bad value and indicates that IDL is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of IDL (-838.82) is worse than 88.24% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -838.82
ROIC/WACCN/A
WACC4.45%
IDL.CA Yearly LT Debt VS Equity VS FCFIDL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

IDL has a Current Ratio of 0.02. This is a bad value and indicates that IDL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of IDL (0.02) is worse than 94.12% of its industry peers.
IDL has a Quick Ratio of 0.02. This is a bad value and indicates that IDL is not financially healthy enough and could expect problems in meeting its short term obligations.
IDL's Quick ratio of 0.02 is on the low side compared to the rest of the industry. IDL is outperformed by 94.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
IDL.CA Yearly Current Assets VS Current LiabilitesIDL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for IDL have decreased strongly by -40.12% in the last year.
The Revenue has grown by 38.60% in the past year. This is a very strong growth!
Measured over the past years, IDL shows a very negative growth in Revenue. The Revenue has been decreasing by -37.84% on average per year.
EPS 1Y (TTM)-40.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.56%
Revenue 1Y (TTM)38.6%
Revenue growth 3Y-37.08%
Revenue growth 5Y-37.84%
Sales Q2Q%157.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IDL.CA Yearly Revenue VS EstimatesIDL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IDL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IDL.CA Price Earnings VS Forward Price EarningsIDL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IDL.CA Per share dataIDL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IDL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMAGING DYNAMICS CO LTD

TSX-V:IDL (10/14/2025, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-28 2025-05-28
Earnings (Next)08-27 2025-08-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.44%
Ins Owner ChangeN/A
Market Cap309.90K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.47
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.01
BVpS-0.53
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -704.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.79%
FCFM N/A
ROA(3y)-343.3%
ROA(5y)-260.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.86%
GM growth 5Y-2.44%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.69%
Cap/Sales 4.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -838.82
F-Score5
WACC4.45%
ROIC/WACCN/A
Cap/Depr(3y)10.74%
Cap/Depr(5y)26.91%
Cap/Sales(3y)7.84%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.6%
Revenue growth 3Y-37.08%
Revenue growth 5Y-37.84%
Sales Q2Q%157.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.98%
OCF growth 3YN/A
OCF growth 5YN/A